Balentine LLC Viatris Inc Transaction History

Balentine LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$9.2 - $12.26 $147,025 - $195,927	-15,981 Reduced 25.05%	47,818 $460,000
Q4 2022 Jan 31, 2023	BUY	$8.72 - $11.56 $321,419 - $426,101	36,860 Added 136.83%	63,799 $710,000
Q3 2022 Oct 26, 2022	SELL	$8.48 - $11.13 $725,116 - $951,715	-85,509 Reduced 76.04%	26,939 $230,000
Q2 2022 Oct 26, 2022	BUY	$9.95 - $12.27 $661,824 - $816,139	66,515 Added 144.81%	112,448 $1.18 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $661,824 - $816,139	66,515 Added 144.81%	112,448 $1.18 Million
Q1 2022 Oct 26, 2022	SELL	$9.81 - $15.4 $652,512 - $1.02 Million	-66,515 Reduced 59.15%	45,933 $500,000
Q1 2022 May 06, 2022	BUY	$9.81 - $15.4 $450,602 - $707,368	45,933 New	45,933 $500,000
Q4 2021 Feb 02, 2022	SELL	$12.09 - $14.68 $362,361 - $439,988	-29,972 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $397,129 - $453,476	29,972 New	29,972 $406,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.